TLC Vision Corporation (Nasdaq: TLCV) 34% LOWER; reports Q4 loss of $1.89, which may not compare to the analyst estimate of ($0.09) and versus a loss of $0.37 reported in the same quarter last year. Revenue for the quarter was $53.7 million, versus the consensus of $47.84 million.

TBS International Limited (NASDAQ: TBSI) 19.4% HIGHER; reports Q4 EPS of $1.15, versus $1.26 reported in Q407. Revenue for the quarter was $139.8 million, compared to $114 million in the same quarter last year.

Acorda Therapeutics, Inc. (Nasdaq: ACOR) 17.3% LOWER; received a refuse to file letter from the U.S. FDA